Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ACADIA Pharmaceuticals Inc.
Age
55–95
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has successfully completed ACP-204-006 study
Male or female (age 55 to 95 years old): female must be of non-childbearing potential, male must take appropriate contraceptive method if partner has childbearing potential
Subject has a designated study partner/caregiver
Subjects are able to complete all study visits with a study partner/caregiver
Signed inform consent form with a caregiver or legal representative
You may not be if
Requires treatment with a medication prohibited by the protocol
Is in hospice and receiving end-of-life palliative care, or has become bedridden
Unstable clinically significant medical condition other than AD
Any medical condition that in the opinion of the investigator may affect safety or ability to complete the study
Clareo Health | ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
